BIOVF Statistics
Total Valuation
BIOVF has a market cap or net worth of 10.08 billion. The enterprise value is 11.55 billion.
| Market Cap | 10.08B |
| Enterprise Value | 11.55B |
Important Dates
The last earnings date was Wednesday, February 5, 2025.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.01% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 219.81M |
Valuation Ratios
The trailing PE ratio is 28.72.
| PE Ratio | 28.72 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.92, with an EV/FCF ratio of 17.70.
| EV / Earnings | 32.89 |
| EV / Sales | 4.72 |
| EV / EBITDA | 12.92 |
| EV / EBIT | 21.07 |
| EV / FCF | 17.70 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.04 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.76 |
| Debt / FCF | 2.32 |
| Interest Coverage | 4.79 |
Financial Efficiency
Return on equity (ROE) is 10.46% and return on invested capital (ROIC) is 6.55%.
| Return on Equity (ROE) | 10.46% |
| Return on Assets (ROA) | 4.88% |
| Return on Invested Capital (ROIC) | 6.55% |
| Return on Capital Employed (ROCE) | 9.28% |
| Revenue Per Employee | 1.28M |
| Profits Per Employee | 190,779 |
| Employee Count | 1,840 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.89% in the last 52 weeks. The beta is 0.26, so BIOVF's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +12.89% |
| 50-Day Moving Average | 26.23 |
| 200-Day Moving Average | 23.20 |
| Relative Strength Index (RSI) | 56.87 |
| Average Volume (20 Days) | 660 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOVF had revenue of 2.35 billion and earned 351.03 million in profits. Earnings per share was 1.02.
| Revenue | 2.35B |
| Gross Profit | 1.84B |
| Operating Income | 527.05M |
| Pretax Income | 398.20M |
| Net Income | 351.03M |
| EBITDA | 859.47M |
| EBIT | 527.05M |
| Earnings Per Share (EPS) | 1.02 |
Balance Sheet
The company has 103.01 million in cash and 1.51 billion in debt, giving a net cash position of -1.41 billion.
| Cash & Cash Equivalents | 103.01M |
| Total Debt | 1.51B |
| Net Cash | -1.41B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.64B |
| Book Value Per Share | 10.60 |
| Working Capital | 50.78M |
Cash Flow
In the last 12 months, operating cash flow was 667.55 million and capital expenditures -15.36 million, giving a free cash flow of 652.19 million.
| Operating Cash Flow | 667.55M |
| Capital Expenditures | -15.36M |
| Free Cash Flow | 652.19M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.09%, with operating and profit margins of 22.41% and 14.93%.
| Gross Margin | 78.09% |
| Operating Margin | 22.41% |
| Pretax Margin | 16.93% |
| Profit Margin | 14.93% |
| EBITDA Margin | 36.55% |
| EBIT Margin | 22.41% |
| FCF Margin | 27.73% |
Dividends & Yields
BIOVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.01% |
| Shareholder Yield | -6.01% |
| Earnings Yield | 3.48% |
| FCF Yield | 6.47% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOVF has an Altman Z-Score of 2.7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.7 |
| Piotroski F-Score | n/a |